Dr Reddys Laboratories (RDY) EBIT Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) EBIT Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 4.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 40.17% |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 23.55% |
| Mar 31, 2023 | 24.45% |
| Sep 30, 2022 | 13,360.84% |
| Jun 30, 2021 | 32.54% |
| Mar 31, 2021 | 10.48% |
| Sep 30, 2020 | -44.85% |
| Sep 30, 2019 | -39.80% |
| Mar 31, 2019 | -0.59% |
| Dec 31, 2018 | -5.76% |
| Sep 30, 2018 | -10.04% |
| Jun 30, 2018 | -20.82% |
| Dec 31, 2017 | -26.44% |
| Sep 30, 2017 | -17.47% |
| Dec 31, 2016 | -14.32% |
| Sep 30, 2016 | -7.17% |
| Mar 31, 2016 | 17.65% |
| Dec 31, 2015 | -12.22% |
| Sep 30, 2015 | -6.17% |
| Jun 30, 2015 | -70.04% |
| Dec 31, 2014 | -71.36% |